ATE218885T1 - Neue medizinische verwendung eines ace-inhibitors zur behandlung dyspeptischer symptome - Google Patents

Neue medizinische verwendung eines ace-inhibitors zur behandlung dyspeptischer symptome

Info

Publication number
ATE218885T1
ATE218885T1 AT96944722T AT96944722T ATE218885T1 AT E218885 T1 ATE218885 T1 AT E218885T1 AT 96944722 T AT96944722 T AT 96944722T AT 96944722 T AT96944722 T AT 96944722T AT E218885 T1 ATE218885 T1 AT E218885T1
Authority
AT
Austria
Prior art keywords
treatment
medical use
pct
ace inhibitor
new medical
Prior art date
Application number
AT96944722T
Other languages
English (en)
Inventor
Lars Faendriks
Anders Pettersson
Original Assignee
Pharmacore Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacore Ab filed Critical Pharmacore Ab
Application granted granted Critical
Publication of ATE218885T1 publication Critical patent/ATE218885T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/062—Copolymers with monomers not covered by C09J133/06
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/04—Homopolymers or copolymers of esters
    • C09J133/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C09J133/08—Homopolymers or copolymers of acrylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00795—Plasters special helping devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00846—Plasters with transparent or translucent part
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/28—Non-macromolecular organic substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Liquid Crystal Substances (AREA)
AT96944722T 1996-01-15 1996-12-20 Neue medizinische verwendung eines ace-inhibitors zur behandlung dyspeptischer symptome ATE218885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600120A SE9600120D0 (sv) 1996-01-15 1996-01-15 Novel medical use
PCT/SE1996/001733 WO1997026014A1 (en) 1996-01-15 1996-12-20 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms

Publications (1)

Publication Number Publication Date
ATE218885T1 true ATE218885T1 (de) 2002-06-15

Family

ID=20401013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96944722T ATE218885T1 (de) 1996-01-15 1996-12-20 Neue medizinische verwendung eines ace-inhibitors zur behandlung dyspeptischer symptome

Country Status (32)

Country Link
US (1) US5977159A (de)
EP (1) EP0876158B1 (de)
JP (1) JP2001501908A (de)
KR (1) KR19990076973A (de)
CN (1) CN1090031C (de)
AT (1) ATE218885T1 (de)
AU (1) AU710846B2 (de)
BR (1) BR9612483A (de)
CA (1) CA2240199A1 (de)
CZ (1) CZ222398A3 (de)
DE (1) DE69621834T2 (de)
DK (1) DK0876158T3 (de)
EE (1) EE03517B1 (de)
ES (1) ES2175182T3 (de)
HU (1) HUP9901353A3 (de)
ID (1) ID16186A (de)
IL (1) IL125195A (de)
IS (1) IS4778A (de)
MX (1) MX9805506A (de)
MY (1) MY129782A (de)
NO (1) NO983234L (de)
NZ (1) NZ325973A (de)
PL (1) PL327818A1 (de)
PT (1) PT876158E (de)
RU (1) RU2203092C2 (de)
SE (1) SE9600120D0 (de)
SI (1) SI0876158T1 (de)
SK (1) SK282781B6 (de)
TR (1) TR199801298T2 (de)
UA (1) UA49861C2 (de)
WO (1) WO1997026014A1 (de)
ZA (1) ZA9783B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012110A2 (en) * 1998-08-26 2000-03-09 Queen's University At Kingston Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
WO2002087504A2 (en) * 2001-05-01 2002-11-07 University Of Southern California Methods for inhibiting tumor cell proliferation
AU2003217916A1 (en) * 2002-03-08 2003-09-22 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
US20050271657A1 (en) * 2004-06-08 2005-12-08 Australian Stem Cell Centre Ltd. Intermittent treatment regime for organ failure
US7776831B2 (en) 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
WO2009114461A2 (en) * 2008-03-10 2009-09-17 University Of Southern California Angiotensin (1-7) dosage forms and uses thereof
EP2350031A2 (de) * 2008-08-20 2011-08-03 Ensemble Therapeutics Corporation Makrocyclische verbindungen zur inhibierung des tumornekrosefaktors alpha
TW201039839A (en) * 2009-03-27 2010-11-16 Calpis Co Ltd Composition for regulating antonomic nervous activity and method for regulating autonomic nervous
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA899367B (en) * 1988-12-22 1990-08-29 Yamanouchi Pharma Co Ltd 4,5,6,7-tetrahydrobenzimidazole derivatives
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension

Also Published As

Publication number Publication date
WO1997026014A1 (en) 1997-07-24
HK1014870A1 (en) 1999-10-08
JP2001501908A (ja) 2001-02-13
RU2203092C2 (ru) 2003-04-27
EP0876158A1 (de) 1998-11-11
CN1207685A (zh) 1999-02-10
SI0876158T1 (en) 2002-12-31
ZA9783B (en) 1997-07-15
DE69621834T2 (de) 2003-03-06
CA2240199A1 (en) 1997-07-24
AU1323797A (en) 1997-08-11
PT876158E (pt) 2002-10-31
US5977159A (en) 1999-11-02
SE9600120D0 (sv) 1996-01-15
IS4778A (is) 1998-06-19
MY129782A (en) 2007-04-30
HUP9901353A3 (en) 2000-05-29
MX9805506A (es) 1998-11-30
ID16186A (id) 1997-09-11
IL125195A (en) 2001-11-25
DE69621834D1 (de) 2002-07-18
SK87998A3 (en) 1998-12-02
IL125195A0 (en) 1999-03-12
SK282781B6 (sk) 2002-12-03
CN1090031C (zh) 2002-09-04
PL327818A1 (en) 1999-01-04
HUP9901353A2 (hu) 1999-08-30
AU710846B2 (en) 1999-09-30
UA49861C2 (uk) 2002-10-15
BR9612483A (pt) 1999-07-13
CZ222398A3 (cs) 1998-11-11
NZ325973A (en) 2001-05-25
KR19990076973A (ko) 1999-10-25
EE9800203A (et) 1998-12-15
NO983234D0 (no) 1998-07-14
EE03517B1 (et) 2001-10-15
NO983234L (no) 1998-07-14
EP0876158B1 (de) 2002-06-12
TR199801298T2 (xx) 1998-10-21
DK0876158T3 (da) 2002-08-19
ES2175182T3 (es) 2002-11-16

Similar Documents

Publication Publication Date Title
ATE218885T1 (de) Neue medizinische verwendung eines ace-inhibitors zur behandlung dyspeptischer symptome
ATE180166T1 (de) Pflanzliche aktive wirkstoffe enthaltende pharmazeutische zubereitungen,verfahren zur herstellung und verwendung zu medizinischen und veterinaeren zwecken
ES2178157T3 (es) Tratamiento de arritmias mediante la inhibicion de una proteina quinasa multifuncional dependiente de calcio/calmodulina.
SE9604793D0 (sv) New polymorphs
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
NO971566L (no) Fremgangsmåte for behandling av diabetes mellitus ved anvendelse av KGF
ATE156839T1 (de) Neue delta-17 und delta-20 ungesätigte und gesatigte 17--g(b)-substituierte-4-aza-5-g(a)- androstan-3-on verbindungen als inhibitoren von 5-alpha-reductase
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DE69620186D1 (de) Neue medizinische verwendung
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
DE69636393D1 (de) Montirelin zur verhinderung der schlafapnoe
DE69526584D1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DK0651764T3 (da) Cytotoksisk T-lymfocytantigen som cysteinproteaseinhibitor
NO972435L (no) 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
UA38590A (uk) Спосіб лікування гломерулонефриту з анефротичним синдромом та гематуричним компонентом

Legal Events

Date Code Title Description
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee